Technoeconomic analysis (TEA) studies are vital for formulating guidelines that drive the commercialization of electrochemical CO reduction (eCOR) technologies. In this review, we first discuss the progress in the field of eCOR processes by providing current state-of-the-art metrices (e.g., faradic efficiency, current density) based on the recent heterogeneous catalysts' discovery, electrolytes, electrolyzers configuration, and electrolysis process designs. Next, we assessed the TEA studies for a wide range of eCOR final products, different modes of eCOR systems/processes, and discussed their relative competitiveness with relevant commercial products. Finally, we discuss challenges and future directions essential for eCOR commercialization by linking suggestions from TEA studies. We believe that this review will catalyze innovation in formulating advanced eCOR strategies to meet the TEA benchmarks for the conversion of CO into valuable chemicals at the industrial scale.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562736PMC
http://dx.doi.org/10.1021/acs.estlett.4c00564DOI Listing

Publication Analysis

Top Keywords

tea studies
12
technoeconomic analysis
8
ecor
6
electrochemical conversion
4
conversion commercialization
4
commercialization pathways
4
pathways concise
4
concise review
4
review experimental
4
experimental frontiers
4

Similar Publications

Background: Hyperuricemia (HUA) is a condition characterized by excessive uric acid production and/or inadequate uric acid excretion due to abnormal purine metabolism in the human body. Uric acid deposits resulting from HUA can lead to complications such as renal damage. Currently, drugs used to treat HUA lack specificity and often come with specific toxic side effects.

View Article and Find Full Text PDF

Cisplatin is widely used for the treatment of solid tumors and its antitumor effects are well established. However, a known complication of cisplatin administration is acute kidney injury (AKI). In this study, we examined the role of TEA domain family member 1 (TEAD1) in the pathogenesis of cisplatin-induced AKI.

View Article and Find Full Text PDF

Embelin (EMB) and Piperine (PIP) alkaloids are reported for -antidiabetic, hypolipidemic, antioxidant, and anti-cancer properties. However, simultaneous analytical methods are scarce. A stability-indicating RP-HPLC method was developed with mobile phase MeOH: 0.

View Article and Find Full Text PDF

Albendazole serves as a broad-spectrum anthelmintic medication for treating hydatid cysts and neurocysticercosis. However, its therapeutic effectiveness is limited by poor solubility. Nanocrystals offer a promising technology to address this limitation by enhancing drug solubility.

View Article and Find Full Text PDF

Catechins, the main active components of tea polyphenols, boast remarkable antioxidant activities because of their unique structures. This translates to a range of potential health benefits, including fighting antibacterial, inflammation, and even cancers. However, extracting these beneficial compounds can be tricky as they're prone to degradation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!